ICORG Press Release - 15th April 2013
ICORG is proud to play an important role in the development of a Significant new cancer medicine – Palbociclib – for the treatment of advanced/metastatic breast cancer.
ICORG is proud to play an important role in the development of a Significant new cancer medicine – Palbociclib – for the treatment of advanced/metastatic breast cancer.
A Two Day Course outlining the Principles and Practice of Modern Multidisciplinary Translational Cancer Research will take place on Friday 19th & 26th April 2013 in NICB Seminar Room, Dublin City University.
Dr. Dennis Slamon – one of the foremost cancer researchers in the world today – will give a public talk on Thursday 28th February 2013 at 8pm in JM Synge Lecture Theatre, Trinity College Dublin.
An International Melanoma Workshop will take place in the Conway Institute, UCD on the 8th & 9th May.
If you would like to be part of a team working in Oncology where important breakthroughs happen all the time, check out our current Vacancies
4th February marks World Cancer Day.
Today (17th January) saw an important milestone in the ICORG 11-10 / TH v THL study achieved.
ICORG Christmas Cards are now available to purchase.
All funds will go directly to support ICORG’s role in Cancer Clinical Research.
The results of the TRIO 018 Clinical Trial indicated that the combination of Investigational Agent and Letrozole demonstrated clinical benefit in Advanced ER-positive Breast Cancer.